These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10987610)

  • 1. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up.
    Lakkis NM; Nagueh SF; Dunn JK; Killip D; Spencer WH
    J Am Coll Cardiol; 2000 Sep; 36(3):852-5. PubMed ID: 10987610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Ommen SR; Lakkis NM; Killip D; Zoghbi WA; Schaff HV; Danielson GK; Quiñones MA; Tajik AJ; Spencer WH
    J Am Coll Cardiol; 2001 Nov; 38(6):1701-6. PubMed ID: 11704383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy.
    Shamim W; Yousufuddin M; Wang D; Henein M; Seggewiss H; Flather M; Coats AJ; Sigwart U
    N Engl J Med; 2002 Oct; 347(17):1326-33. PubMed ID: 12397190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.
    Knight C; Kurbaan AS; Seggewiss H; Henein M; Gunning M; Harrington D; Fassbender D; Gleichmann U; Sigwart U
    Circulation; 1997 Apr; 95(8):2075-81. PubMed ID: 9133518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
    J Am Coll Cardiol; 1999 Oct; 34(4):1123-8. PubMed ID: 10520801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy.
    Lakkis NM; Nagueh SF; Kleiman NS; Killip D; He ZX; Verani MS; Roberts R; Spencer WH
    Circulation; 1998 Oct; 98(17):1750-5. PubMed ID: 9788829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
    Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of controlled septal infarct in hypertrophic obstructive cardiomyopathy.
    Nielsen CD; Spencer WH
    Cardiol Rev; 2002; 10(2):108-18. PubMed ID: 11895577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy.
    Dimitrow PP; Podolec P; Grodecki J; Płazak W; Dudek D; Pieniazek P; Bacior B; Legutko J; Olszowska M; Kostkiewicz M; Kawecka-Jaszcz K; Tracz W; Dubiel JS
    Int J Cardiol; 2004 Mar; 94(1):31-4. PubMed ID: 14996471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures.
    Nielsen CD; Killip D; Spencer WH
    Clin Cardiol; 2003 Jun; 26(6):275-9. PubMed ID: 12839045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
    van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Rigopoulos A; Welge D; Ziemssen P; Faber L
    Clin Res Cardiol; 2007 Dec; 96(12):856-63. PubMed ID: 17891517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
    Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
    J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
    Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
    Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.
    Ferrazzi P; Spirito P; Iacovoni A; Calabrese A; Migliorati K; Simon C; Pentiricci S; Poggio D; Grillo M; Amigoni P; Iascone M; Mortara A; Maron BJ; Senni M; Bruzzi P
    J Am Coll Cardiol; 2015 Oct; 66(15):1687-96. PubMed ID: 26449139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
    Circulation; 1999 Jan; 99(3):344-7. PubMed ID: 9918519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
    Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
    Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
    Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
    Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
    Clin Res Cardiol; 2007 Dec; 96(12):864-73. PubMed ID: 17891518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.